Biotech M&A Anomalies With Allan Shaw
Business Of Biotech
00:00
The Business of Biotech Podcast - Backslash Emerging Biotech
Portage's pipeline is incredibly deep and growing. One of the programs can go in by the end of the year, another one next year once we get the drug supply. We saw something that we can actually create value, de-risk a lot sooner. The podcast is brought to you in collaboration with siteiva.com backslash emerging biotech.
Transcript
Play full episode
